Indexing powder patterns in physical form screening: instrumentation and data quality.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Pharmacy and Science

• Publication date

  2003-09-01

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1002/JPS.10459PMID 12950010
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Cambridge Structural Database: a quarter of a million crystal structures and rising.

  2002cited by this paper
• The Powder Diffraction File: present and future.

  2002cited by this paper
• Molecular, crystallographic and algorithmic factors in structure determination from powder diffraction data by simulated annealing

  2002cited by this paper
• Indexing of powder diffraction patterns for low-symmetry lattices by the successive dichotomy method

  1991cited by this paper
• Correction of intensities for preferred orientation in powder diffractometry: application of the March model

  1986cited by this paper
• A novel curved position-sensitive proportional counter for X-ray diffractometry

  1983cited by this paper
• X-Ray diffraction procedures for polycrystalline and amorphous materials

  1974cited by this paper
• X-Ray Diffraction Procedures for Polycrystalline and Amorphous Materials.

  1955cited by this paper
• JOURNAL OF PHARMACEUTICAL SCIENCES

  year unknowncited by this paper

• Improving the catalytic performance of LaNiO3 perovskite by manganese substitution via ultrasonic spray pyrolysis for dry reforming of methane

  2021cites this paper
• Halliwell, Rebecca A. and Bhardwaj, Rajni M. and Brown, Cameron and Briggs, Naomi E. B. and Dunn, Jaclyn and Robertson, John and Nordon, Alison and Florence, Alastair J. (2017) Spray drying as a reliable route to produce metastable carbamazepine form

  2019cites this paper
• Pushing the Limits of Molecular Crystal Structure Determination From Powder Diffraction Data in High-Throughput Chemical Environments.

  2018cites this paper
• Spray Drying as a Reliable Route to Produce Metastable Carbamazepine Form IV.

  2017cites this paper
• Improved performance of crystal structure solution from powder diffraction data through parameter tuning of a simulated annealing algorithm

  2017cites this paper
• Improved crystal structure solution from powder diffraction data by the use of conformational information

  2017cites this paper
• Crystal structure of the co-crystal butylparaben–isonicotinamide (1/1)

  2016cites this paper
• Crystal structure of a mixed solvated form of amoxapine acetate

  2015cites this paper
• Validation of molecular crystal structures from powder diffraction data with dispersion-corrected density functional theory (DFT-D)

  2014cites this paper
• Structure and stability of two polymorphs of creatine and its monohydrate

  2014cites this paper
• 1. Powder Diffraction

  2014cites this paper
• 2-Methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine (olanzapine) propan-2-ol disolvate

  2013cites this paper
• Exploring the Experimental and Computed Crystal Energy Landscape of Olanzapine

  2013cites this paper
• In situ monitoring of stirring effects on polymorphic transformations during cooling crystallization of carbamazepine

  2012cites this paper
• Tracking the structural changes in a series of cholesterol solvates

  2012cites this paper
• TALP: a multisolution direct‐space strategy for solving molecular crystals from powder diffraction data based on restrained least squares

  2012influential citation
• Polymer templating of supercooled indomethacin for polymorph selection.

  2012cites this paper
• 6-Methyl-1,3,5-triazine-2,4-diamine butane-1,4-diol monosolvate

  2012cites this paper
• Analysis of nonvalent interactions in the crystals of conformational polymorphs of the composition CaHbNcOdSe by means of molecular voronoi-dirichlet polyhedra

  2011cites this paper
• Experimental and predicted crystal energy landscapes of chlorothiazide

  2011cites this paper
• A predicted dimer-based polymorph of 10,11-dihydrocarbamazepine (Form IV)

  2010cites this paper
• Putting pressure on elusive polymorphs and solvates

  2009cites this paper
• 3-Aminocarbonylpyridinium difluoroacetate at 123 K

  2009cites this paper
• Nicotinamide–2,2,2-trifluoroethanol (2/1)

  2009cites this paper
• Cytenamide–formic acid (1/1)

  2008cites this paper
• Urea–N,N-dimethylacetamide (1/1)

  2008cites this paper
• Cytenamide acetic acid solvate

  2008cites this paper
• Cytenamide–butyric acid (1/1)

  2008cites this paper
• Chlorothiazide–pyridine (1/3)

  2008cites this paper
• Targeted crystallisation of novel carbamazepine solvates based on a retrospective Random Forest classification

  2008cites this paper
• Screening strategies based on solubility and solution composition generate pharmaceutically acceptable cocrystals of carbamazepine

  2008cites this paper
• Cytenamide–1,4-dioxane (2/1)

  2008cites this paper
• Cytenamide trifluoroacetic acid solvate

  2008cites this paper
• Chlorothiazide formic acid solvate (1/2)

  2007cites this paper
• New solid-state chemistry technologies to bring better drugs to market: knowledge-based decision making

  2007cites this paper
• Urea–N,N‐dimethylformamide (3/1)

  2007cites this paper
• Hydroflumethiazide dimethyl sulfoxide disolvate

  2007cites this paper
• 10,11-dihydrocarbamazepine-form-amide solvate (1/1)

  2007cites this paper
• Chlorothiazide dimethyl sulfoxide solvate

  2007cites this paper
• Miniaturized Assay for Solubility and Residual Solid Screening (SORESOS) in Early Drug Development

  2007cites this paper
• 10,11-dihydrocarbamazepine formic acid solvate

  2007cites this paper
• Carbamazepine trifluoroacetic acid solvate

  2007cites this paper
• Chlorothiazide N,N-dimethylacetamidedisolvate

  2007cites this paper
• Hydrochlorothiazide dimethyl sulfoxide solvate

  2006cites this paper
• Hydrochlorothiazide N-methyl-2-pyrrolidone disolvate

  2006cites this paper
• 10,11-Dihydrocarbamazepine-acetic acid (1/1)

  2006cites this paper
• 3‐Aza­bicyclo­[3.3.1]nonane‐2,4‐dione–acetic acid (1/1)

  2006cites this paper
• Hydro­chloro­thia­zide N,N-dimethyl­acetamide disolvate

  2006cites this paper
• Hydrochlorothiazide N,N-dimethylformamide solvate

  2006cites this paper
• Powder study of chloro­thia­zide N,N-dimethyl­formamide solvate

  2006cites this paper
• An automated platform for parallel crystallization of small organic molecules

  2006cites this paper
• An automated parallel crystallisation search for predicted crystal structures and packing motifs of carbamazepine.

  2006cites this paper
• Powder study of 3-aza­bicyclo­[3.3.1]nonane-2,4-dione 1-methyl­naphthalene hemisolvate

  2006cites this paper
• 3,4-Dichloro-1-nitro­benzene-1,4-dioxane (4/1)

  2005cites this paper
• 3,4-Dichloro-1-nitrobenzene-aniline (2/1)

  2005cites this paper
• Hydrochlorothiazide-aniline (1/1)

  2005cites this paper
• Powder study of hydro­chloro­thia­zide–methyl acetate (1/1)

  2005cites this paper
• Powder study of hydro­chloro­thia­zide form II

  2005cites this paper
• Carbamazepine furfural hemisolvate

  2005cites this paper
• Hydrochlorothiazide-1,4-dioxane(1/1)

  2005cites this paper
• Carbamazepine N,N-dimethylformamide solvate

  2005cites this paper
• Powder diffraction based structural studies of pharmaceuticals

  2004cites this paper
• Powder pattern indexing with the dichotomy method

  2004cites this paper